The CGRP receptor component RAMP1 links sensory innervation with YAP activity in the regenerating liver.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
06 2020
Historique:
received: 24 12 2019
revised: 26 03 2020
accepted: 02 04 2020
pubmed: 25 4 2020
medline: 20 1 2021
entrez: 25 4 2020
Statut: ppublish

Résumé

The effectiveness of liver regeneration limits surgical therapies of hepatic disorders and determines patient outcome. Here, we investigated the role of the neuropeptide calcitonin gene-related peptide (CGRP) for liver regeneration after acute or chronic injury. Mice deficient for the CGRP receptor component receptor activity-modifying protein 1 (RAMP1) were subjected to a 70% partial hepatectomy or repeated intraperitoneal injections of carbon tetrachloride. RAMP1 deficiency severely impaired recovery of organ mass and hepatocyte proliferation after both acute and chronic liver injury. Mechanistically, protein expression of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) was decreased in regenerating livers of RAMP1-deficient mice. Lack of RAMP1 was associated with hyperphosphorylation of YAP on Ser127 and Ser397, which regulates YAP functional activity and protein levels. Consequently, expression of various YAP-controlled cell cycle regulators and hepatocyte proliferation were severely reduced in the absence of RAMP1. In vitro, CGRP treatment caused increased YAP protein expression and a concomitant decline of YAP phosphorylation in liver tissue slice cultures of mouse and human origin and in primary human hepatocytes. Thus, our results indicate that sensory nerves represent a crucial control element of liver regeneration after acute and chronic injury acting through the CGRP-RAMP1 pathway, which stimulates YAP/TAZ expression and activity.

Identifiants

pubmed: 32329113
doi: 10.1096/fj.201903200R
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Cell Cycle Proteins 0
Ramp1 protein, mouse 0
Receptor Activity-Modifying Protein 1 0
Receptors, Calcitonin Gene-Related Peptide 0
YAP-Signaling Proteins 0
Yap1 protein, mouse 0
Calcitonin Gene-Related Peptide JHB2QIZ69Z

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8125-8138

Informations de copyright

© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Références

Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol. 2012;57:692-694.
Alison MR, Lin W-R. Diverse routes to liver regeneration. J Pathol. 2016;238:371-374.
Michalopoulos GK. Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology. 2017;65:1384-1392.
Clavien P-A, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatology. 2010;52:715-729.
Clavien P-A, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-1559.
Berthoud H-R. Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol. 2004;280A:827-835.
Russell FA, King R, Smillie S-J, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099-1142.
Bracq S, Clement B, Pidoux E, Moukhtar MS, Jullienne A. CGRP is expressed in primary cultures of human hepatocytes and in normal liver. FEBS Lett. 1994;351:63-66.
Mizutani T, Yokoyama Y, Kokuryo T, Kawai K, Miyake T, Nagino M. Calcitonin gene-related peptide regulates the early phase of liver regeneration. J Surg Res. 2013;183:138-145.
Booe JM, Walker CS, Barwell J, et al. Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor. Mol Cell. 2015;58:1040-1052.
Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem. 2000;275:31438-31443.
Holzmann B. Antiinflammatory activities of CGRP modulating innate immune responses in health and disease. Curr Protein Pept Sci. 2013;14:268-274.
Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol. 2007;213:589-602.
Kawanami Y, Morimoto Y, Kim H, et al. Calcitonin gene-related peptide stimulates proliferation of alveolar epithelial cells. Respir Res. 2009;10:8-16.
Tsujikawa K, Yayama K, Hayashi T, et al. Hypertension and dysreglated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A. 2007;104:16702-16707.
Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2008;3:1167-11709.
Scholten D, Trebicka J, Liedtke C, Weiskirchen R. The carbon tetrachloride model in mice. Lab Anim. 2015;49:4-11.
de Graaf IAM, Olinga P, de Jager MH, et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc. 2010;5:1540-1551.
Walker CS, Conner AC, Poyner DR, Hay DL. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci. 2010;31:476-483.
Holzmann B. Modulation of immune responses by the neuropeptide CGRP. Amino Acids. 2013;45:1-7.
Gingell JJ, Hendrikse ER, Hay DL. New insights into the regulation of CGRP-family receptors. Trends Pharmacol Sci. 2019;40:71-83.
Yu F-X, Zhao B, Panupinthu N, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780-791.
Yu F-X, Zhang Y, Park HW, et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiatiion. Genes Dev. 2013;27:1223-1232.
Miller E, Yang J, DeRan M, et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol. 2012;19:955-962.
Lu L, Finegold MJ, Johnson RL. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018;50:e423.
Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747-2761.
Zhao B, Li L, Tumaneng K, Wang C-Y, Guan K-L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 2010;24:72-85.
Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: Hippo signaling and beyond. Physiol Rev. 2014;94:1287-1312.
Patel SH, Camargo FD, Yimlamai D. Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology. 2017;152:533-545.
Hansen CG, Moroishi T, Guan K-L. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol. 2015;25:499-513.
Loforese G, Malinka T, Keogh A, et al. Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases Mst1 and Mst2. EMBO Mol Med. 2017;9:46-60.
Zanconato F, Forcato M, Battilana G, et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015;17:1218-1227.
Di Agostino S, Sorrentino G, Ingallina E, et al. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins. EMBO Rep. 2016;17:188-201.
Klein EA, Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci. 2008;121:3853-3857.
Ouwens DM, de Ruiter ND, van der Zon GCM, et al. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 2002;21:3782-3793.
Riehle KJ, Campbell JS, McMahan RS, et al. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med. 2008;205:91-103.
Glaser SS, Ueno Y, DeMorrow S, et al. Knockout of α-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice. Lab Invest. 2007;87:914-926.
Wan Y, Ceci L, Wu N, et al. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes. Lab Invest. 2019;99:764-776.
Hwang IS, Tang F, Leung PP, Li YY, Fan ST, Luk JM. The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis. Regul Pept. 2006;135:69-77.
Ehmer U, Zmoos A-F, Auerbach RK, et al. Organs size control is dominant over Rb family inactivation to restrict proliferation in vivo. Cell Rep. 2014;8:371-381.
Kim AR, Park JI, Oh HT, et al. TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury. FASEB J. 2019;33:5914-5923.
Apte U, Gkretsi V, Bowen WC, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology. 2009;50:844-851.
Liu B, Bell AW, Paranjpe S, et al. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology. 2010;52:1060-1067.
Swiderska-Syn M, Xie G, Michelotti GA, et al. Hedgehog regulates Yes-associated protein 1 in regenerating mouse liver. Hepatology. 2016;64:232-244.
Li JW, Wang GP, Fan JY, Chang CF, Xu CS. Eight paths of ERK1/2 signalling pathway regulating hepatocyte proliferation in rat liver regeneration. J Genet. 2011;90:435-442.

Auteurs

Melanie Laschinger (M)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Yang Wang (Y)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Gabriela Holzmann (G)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Baocai Wang (B)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Christian Stöß (C)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Miao Lu (M)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Marcus Brugger (M)

School of Medicine, Institute of Molecular Immunology & Experimental Oncology, Technical University of Munich, Munich, Germany.

Annika Schneider (A)

School of Medicine, Institute of Molecular Immunology & Experimental Oncology, Technical University of Munich, Munich, Germany.

Percy Knolle (P)

School of Medicine, Institute of Molecular Immunology & Experimental Oncology, Technical University of Munich, Munich, Germany.

Dirk Wohlleber (D)

School of Medicine, Institute of Molecular Immunology & Experimental Oncology, Technical University of Munich, Munich, Germany.

Sarah Schulze (S)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Katja Steiger (K)

School of Medicine, Institute of Pathology, Technical University of Munich, Munich, Germany.

Kazutake Tsujikawa (K)

Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Felicitas Altmayr (F)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Helmut Friess (H)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Daniel Hartmann (D)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Norbert Hüser (N)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Bernhard Holzmann (B)

Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH